Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus

Women and Children's Hospital, Buffalo

Children's Hospital of Pittsburgh, Pittsburgh

Children's Hospital of Philadelphia, Philadelphia

Christiana Care Health Services, Newark

Barry J. Reiner MD, LLC., Baltimore

WakeMed Children's Hospital, Raleigh

Atlanta Diabetes Associates, Atlanta

Solutions Through Advanced Research Inc., Jacksonville

CCM Clinical Research, Miami

Advanced Pharma CR LLC, Miami

University of Louisville, Louisville

Endocrinology Associates Inc, Columbus

Ohio State University, Columbus

Methodist Research Institute, Indianapolis

Wayne State University, Detroit

University of Iowa Hospitals and Clinics, Iowa City

Children's Hospitals and Clinics of Minnesota, Saint Paul

Rapid City Regional Hospital/Health Clinical Research, Rapid City

Cook County Hospital, Chicago

Pediatric Endocrinology, Genetics & Metabolism, Oklahoma City

Research Institute of Dallas, Dallas

University of Texas Southwestern Medical Center, Dallas

Northeast Clinical Research of San Antonio LLC, San Antonio

University of Texas Health Science Center, San Antonio

Consano Clinical Research, San Antonio

Rocky Mountain Diabetes and Osteoporosis Center, Idaho Falls

University of Arizona, Tucson

Clinica Medica San Miguel, Los Angeles

Metabolic Institute of America, Tarzana

Rady Children's Hospital San Diego, San Diego

Diabetes Associates Medical Group, Orange

Ronald H Chochinov MD, Ventura

Yale New Haven Hospital, New Haven

UMass Memorial Medical Center, Worcester

Morristown Medical Center, Morristown

University of New Mexico, Health Sciences Center, Albuquerque